Feb 24, 2016 13:30 pm UTC| Business
SAN DIEGO, Feb. 24, 2016 -- Retrophin, Inc.(NASDAQ:RTRX) today announced that theEuropean Commission has granted orphan drug designation to RE-024, the Company’s novel investigational phosphopantothenate replacement...
ABM Industries to Announce First Quarter 2016 Earnings Results
Feb 24, 2016 13:30 pm UTC| Business
NEW YORK, Feb. 24, 2016 -- ABM Industries Incorporated (NYSE:ABM), a leading provider of facility solutions, will release its earnings results for the Company’s first fiscal quarter of 2016 on Tuesday, March 8, 2016...
Feb 24, 2016 13:30 pm UTC| Business
SAN FRANCISCO, Feb. 24, 2016 -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm announces the filing of a securities fraud class action lawsuit against The Boeing Company (NYSE:BA) related to...
Cerner to Webcast Investment Community Meeting
Feb 24, 2016 13:30 pm UTC| Business
KANSAS CITY, Mo., Feb. 24, 2016 -- Cerner (Nasdaq:CERN) announced today that it will make its 2016 Investment Community Meeting available through a webcast on March 2. The webcast will begin at 9:00 a.m. PST and end at...
Feb 24, 2016 13:30 pm UTC| Business
DANBURY, Conn., Feb. 24, 2016 -- FuelCell Energy, Inc. (Nasdaq:FCEL), a global leader in the design, manufacture, operation and service of ultra-clean, efficient and reliable fuel cell power plants, announced the...
Galectin Therapeutics Receives U.S. Patent Allowance for GR-MD-02 to Treat Pulmonary Fibrosis
Feb 24, 2016 13:30 pm UTC| Business
NORCROSS, Ga. , Feb. 24, 2016 -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announces receipt of a Notice of Allowance...
Feb 24, 2016 13:30 pm UTC| Business
SALT LAKE CITY, Feb. 24, 2016 -- Park City Group’s ReposiTrak®, the leading provider of Compliance Management and Track Trace solutions for food, pharma and dietary supplement safety, announces the launch of the...